chr9-69385787-TA-T
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_001347995.2(ENTREP1):c.1163-5delA variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0381 in 934,706 control chromosomes in the GnomAD database, including 1,826 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.090 ( 238 hom., cov: 0)
Exomes 𝑓: 0.035 ( 1588 hom. )
Consequence
ENTREP1
NM_001347995.2 splice_region, intron
NM_001347995.2 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.11
Genes affected
ENTREP1 (HGNC:24820): (endosomal transmembrane epsin interactor 1) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 9-69385787-TA-T is Benign according to our data. Variant chr9-69385787-TA-T is described in ClinVar as [Benign]. Clinvar id is 161521.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.181 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ENTREP1 | NM_001347995.2 | c.1163-5delA | splice_region_variant, intron_variant | ENST00000303068.14 | NP_001334924.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENTREP1 | ENST00000303068.14 | c.1163-5delA | splice_region_variant, intron_variant | 2 | NM_001347995.2 | ENSP00000304435.8 |
Frequencies
GnomAD3 genomes AF: 0.0901 AC: 4664AN: 51782Hom.: 239 Cov.: 0
GnomAD3 genomes
AF:
AC:
4664
AN:
51782
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.122 AC: 5020AN: 41060Hom.: 1126 AF XY: 0.113 AC XY: 2381AN XY: 21102
GnomAD3 exomes
AF:
AC:
5020
AN:
41060
Hom.:
AF XY:
AC XY:
2381
AN XY:
21102
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0350 AC: 30931AN: 882894Hom.: 1588 Cov.: 34 AF XY: 0.0366 AC XY: 15509AN XY: 423402
GnomAD4 exome
AF:
AC:
30931
AN:
882894
Hom.:
Cov.:
34
AF XY:
AC XY:
15509
AN XY:
423402
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0902 AC: 4673AN: 51812Hom.: 238 Cov.: 0 AF XY: 0.0928 AC XY: 2303AN XY: 24810
GnomAD4 genome
AF:
AC:
4673
AN:
51812
Hom.:
Cov.:
0
AF XY:
AC XY:
2303
AN XY:
24810
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Malignant tumor of prostate Uncertain:1
Uncertain significance, no assertion criteria provided | literature only | Science for Life laboratory, Karolinska Institutet | - | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 01, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at